1. Home
  2. ESTC vs MDAIW Comparison

ESTC vs MDAIW Comparison

Compare ESTC & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESTC
  • MDAIW
  • Stock Information
  • Founded
  • ESTC 2012
  • MDAIW N/A
  • Country
  • ESTC Netherlands
  • MDAIW United States
  • Employees
  • ESTC N/A
  • MDAIW 78
  • Industry
  • ESTC Computer Software: Prepackaged Software
  • MDAIW Medical/Dental Instruments
  • Sector
  • ESTC Technology
  • MDAIW Health Care
  • Exchange
  • ESTC Nasdaq
  • MDAIW Nasdaq
  • Market Cap
  • ESTC N/A
  • MDAIW N/A
  • IPO Year
  • ESTC 2018
  • MDAIW N/A
  • Fundamental
  • Price
  • ESTC $80.68
  • MDAIW $0.37
  • Analyst Decision
  • ESTC Buy
  • MDAIW
  • Analyst Count
  • ESTC 26
  • MDAIW 0
  • Target Price
  • ESTC $117.79
  • MDAIW N/A
  • AVG Volume (30 Days)
  • ESTC 2.3M
  • MDAIW 35.6K
  • Earning Date
  • ESTC 05-29-2025
  • MDAIW 02-27-2025
  • Dividend Yield
  • ESTC N/A
  • MDAIW N/A
  • EPS Growth
  • ESTC N/A
  • MDAIW N/A
  • EPS
  • ESTC N/A
  • MDAIW N/A
  • Revenue
  • ESTC $1,483,296,000.00
  • MDAIW $27,264,000.00
  • Revenue This Year
  • ESTC $15.76
  • MDAIW N/A
  • Revenue Next Year
  • ESTC $14.56
  • MDAIW N/A
  • P/E Ratio
  • ESTC N/A
  • MDAIW N/A
  • Revenue Growth
  • ESTC 17.04
  • MDAIW 44.52
  • 52 Week Low
  • ESTC $69.00
  • MDAIW $0.08
  • 52 Week High
  • ESTC $123.96
  • MDAIW $0.90
  • Technical
  • Relative Strength Index (RSI)
  • ESTC 35.71
  • MDAIW N/A
  • Support Level
  • ESTC $90.00
  • MDAIW N/A
  • Resistance Level
  • ESTC $94.29
  • MDAIW N/A
  • Average True Range (ATR)
  • ESTC 2.79
  • MDAIW 0.00
  • MACD
  • ESTC -0.64
  • MDAIW 0.00
  • Stochastic Oscillator
  • ESTC 18.70
  • MDAIW 0.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: